Literature DB >> 12162105

Monitoring inflammation in CF. Cytokines.

Scott D Sagel1, Frank J Accurso.   

Abstract

In cystic fibrosis (CF), chronic airway infection and neutrophil-dominated airway inflammation lead to progressive lung disease. Cytokines play an important role in the inflammatory response. Evidence suggests that cytokine production is altered or dysregulated in CF. Moreover, polymorphisms in cytokines may be linked to disease severity by acting as modifier genes. This article reviews the current state of knowledge regarding individual cytokines and CF lung disease, with an eye towards the possibility that cytokines may be used as outcome measures in clinical trials in CF. In addition, cytokines may eventually serve as targets for novel anti-inflammatory therapies in CF.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12162105     DOI: 10.1385/CRIAI:23:1:041

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  90 in total

1.  Proinflammatory cytokine responses to P. aeruginosa infection in human airway epithelial cell lines.

Authors:  D Kube; U Sontich; D Fletcher; P B Davis
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-03       Impact factor: 5.464

2.  Dysregulated cytokine production in human cystic fibrosis bronchial epithelial cells.

Authors:  A A Stecenko; G King; K Torii; R M Breyer; R Dworski; T S Blackwell; J W Christman; K L Brigham
Journal:  Inflammation       Date:  2001-06       Impact factor: 4.092

3.  Increased levels of interleukin-1 in bronchoalveolar washings from children with bacterial pulmonary infections.

Authors:  R W Wilmott; J T Kassab; P L Kilian; W R Benjamin; S D Douglas; R E Wood
Journal:  Am Rev Respir Dis       Date:  1990-08

4.  The chemotactic activity of sputum from patients with bronchiectasis.

Authors:  M Mikami; C G Llewellyn-Jones; D Bayley; S L Hill; R A Stockley
Journal:  Am J Respir Crit Care Med       Date:  1998-03       Impact factor: 21.405

5.  Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction.

Authors:  S D Sagel; R Kapsner; I Osberg; M K Sontag; F J Accurso
Journal:  Am J Respir Crit Care Med       Date:  2001-10-15       Impact factor: 21.405

6.  Cytokines and inflammatory mediators do not indicate acute infection in cystic fibrosis.

Authors:  J M Wolter; R L Rodwell; S D Bowler; J G McCormack
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

7.  Transforming growth factor-beta1 in plasma and liver of children with liver disease.

Authors:  J N Rosensweig; M Omori; K Page; C J Potter; E J Perlman; S S Thorgeirsson; K B Schwarz
Journal:  Pediatr Res       Date:  1998-09       Impact factor: 3.756

8.  Circulating tumor necrosis factor-alpha levels and lipid abnormalities in patients with cystic fibrosis.

Authors:  E Levy; C Gurbindo; F Lacaille; K Paradis; L Thibault; E Seidman
Journal:  Pediatr Res       Date:  1993-08       Impact factor: 3.756

9.  Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases.

Authors:  J B Richman-Eisenstat; P G Jorens; C A Hébert; I Ueki; J A Nadel
Journal:  Am J Physiol       Date:  1993-04

10.  Interleukin-1 alpha, soluble interleukin-2 receptor, and IgG concentrations in cystic fibrosis treated with prednisolone.

Authors:  P Greally; M J Hussain; D Vergani; J F Price
Journal:  Arch Dis Child       Date:  1994-07       Impact factor: 3.791

View more
  13 in total

1.  Lack of cystic fibrosis transmembrane conductance regulator in CD3+ lymphocytes leads to aberrant cytokine secretion and hyperinflammatory adaptive immune responses.

Authors:  Christian Mueller; Sofia A Braag; Allison Keeler; Craig Hodges; Mitchell Drumm; Terence R Flotte
Journal:  Am J Respir Cell Mol Biol       Date:  2010-08-19       Impact factor: 6.914

2.  Long term effects of azithromycin in patients with cystic fibrosis: A double blind, placebo controlled trial.

Authors:  A Clement; A Tamalet; E Leroux; S Ravilly; B Fauroux; J-P Jais
Journal:  Thorax       Date:  2006-06-29       Impact factor: 9.139

Review 3.  Chemoattractants and cytokines in primary ciliary dyskinesia and cystic fibrosis: key players in chronic respiratory diseases.

Authors:  Maaike Cockx; Mieke Gouwy; Jo Van Damme; Sofie Struyf
Journal:  Cell Mol Immunol       Date:  2017-11-27       Impact factor: 11.530

4.  Vitamins A, D, E status as related to supplementation and lung disease markers in young children with cystic fibrosis.

Authors:  HuiChuan J Lai; Lyanne H Chin; Sangita Murali; Taiya Bach; Danielle Sander; Philip M Farrell
Journal:  Pediatr Pulmonol       Date:  2022-01-20

5.  HE3286, an oral synthetic steroid, treats lung inflammation in mice without immune suppression.

Authors:  Douglas Conrad; Angela Wang; Raymond Pieters; Ferdinando Nicoletti; Katia Mangano; Anna M van Heeckeren; Steven K White; James M Frincke; Christopher L Reading; Dwight Stickney; Dominick L Auci
Journal:  J Inflamm (Lond)       Date:  2010-10-30       Impact factor: 4.981

Review 6.  Sputum biomarkers of inflammation in cystic fibrosis lung disease.

Authors:  Scott D Sagel; James F Chmiel; Michael W Konstan
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

Review 7.  Gene therapy for cystic fibrosis.

Authors:  Christian Mueller; Terence R Flotte
Journal:  Clin Rev Allergy Immunol       Date:  2008-12       Impact factor: 8.667

8.  Potential role of high-mobility group box 1 in cystic fibrosis airway disease.

Authors:  Steven M Rowe; Patricia L Jackson; Gang Liu; Mathew Hardison; Alessandra Livraghi; G Martin Solomon; D Brent McQuaid; Brett D Noerager; Amit Gaggar; J P Clancy; Wanda O'Neal; Eric J Sorscher; Edward Abraham; J Edwin Blalock
Journal:  Am J Respir Crit Care Med       Date:  2008-07-24       Impact factor: 21.405

9.  Anti-inflammatory effect of fluvastatin on IL-8 production induced by Pseudomonas aeruginosa and Aspergillus fumigatus antigens in cystic fibrosis.

Authors:  Stéphane Jouneau; Mélanie Bonizec; Chantal Belleguic; Benoit Desrues; Graziella Brinchault; Jeanne Galaine; Jean-Pierre Gangneux; Corinne Martin-Chouly
Journal:  PLoS One       Date:  2011-08-03       Impact factor: 3.240

10.  The effects of interleukin-8 on airway smooth muscle contraction in cystic fibrosis.

Authors:  Vasanthi Govindaraju; Marie-Claire Michoud; Pasquale Ferraro; Janine Arkinson; Katherine Safka; Hector Valderrama-Carvajal; James G Martin
Journal:  Respir Res       Date:  2008-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.